Current projections of the global parenteral formula market indicate a valuation of USD 6.8 billion by 2024. Looking ahead to 2034, the forecast projects a CAGR of 5.7%. The estimated valuation of USD 12.5 billion in 2034 comes from the growing prevalence of chronic disorders like cancer, kidney failure, and diabetes.
| Attributes | Key Insights |
|---|---|
| Parenteral Formula Market Size (2024E) | USD 6.8 billion |
| Parenteral Formula Market Value (2034F) | USD 12.5 billion |
| Value-based CAGR (2024 to 2034) | 5.7% |
Exclusive Offer: 30% Off on Regional Reports
Get a free sample report and customize your regions for a 30% discount on your regional report!
The global aging population is on the rise, which is leading to age-related conditions and nutritional deficiencies among older adults. Senior citizens often find it difficult to take medicines in oral form due to frailty, dysphagia, or other age-related issues.
The shift in demography in a region is an important factor behind this growth, especially in long-term care facilities and home healthcare settings. Innovations in medication technology have revolutionized the formulation, packaging, and delivery of parenteral nutrition products. With innovations such as multi-chamber bags and closed-system transfer devices, the market is set to rise steadily.
Healthcare providers are anticipated to gain a new opportunity with high demand for personalized nutrition therapy tailored to individual patient needs. They are customizing parenteral formulations based on the patient's age, diagnosis, nutritional status, and metabolic requirements.
There is a rise in the global prevalence of chronic illnesses like diabetes, cancer, and chronic obstructive pulmonary disease (COPD). The majority of such patients are unable to meet their nutritional needs orally.
For them, parenteral formulas are necessary as nutritional solutions can be delivered directly into the bloodstream. Innovations in catheter technology and aseptic processing techniques have also enhanced the safety and efficacy of parenteral nutrition.
Global parenteral formula sales grew at a CAGR of 4.7% from 2019 to 2023. In the next ten years, the parenteral formula market is predicted to surge at 5.7% CAGR.
| Historical CAGR (2019 to 2023) | 4.7% |
|---|---|
| Forecast CAGR (2024 to 2034) | 5.7% |
The parenteral formula industry is growing because of increasing prevalence of chronic illnesses such as diabetes, cancer, and gastrointestinal problems. These are resulting in a growing shift of patients toward parenteral nutrition treatment as they are unable to fulfill their nutritional demands orally.
Rising adoption of parenteral formulas in critical care settings, surgical units, and long-term care facilities is projected to augment demand. These help healthcare providers to support patients with complex medical conditions or those undergoing surgical procedures.
The boom of home healthcare services is also set to create new opportunities. These services enable patients to receive parenteral nutrition therapy outside of traditional hospital settings.
The need for parenteral nutrition support among older persons will increase as the world's population ages, and the prevalence of age-related disorders rises. Parenteral nutrition therapy is anticipated to witness high popularity amid ongoing innovations in patient monitoring technology, delivery methods, and formulations that improve the therapy's efficacy and safety.
The section offers a comprehensive evaluation of two interrelated markets in the food & beverage division. These include the infant formula market and tube-feeding formula market. Analysis of these related industries can provide deeper insights that may be helpful for developing unique differentiating strategies to pursue growth and opportunity in the total parenteral nutrition market.
Parenteral Formula Market:
| Attributes | Parenteral Formula Market/Injectable Nutrition Market |
|---|---|
| CAGR (2024 to 2034) | 5.7% |
| Growth Factor | Increasing cases of malnutrition across economically deprived countries are set to push the parenteral nutrition solution market. |
| Trends in the Parenteral Formula Market | High rate of premature births is compelling key companies to innovate their existing formulations. |
| Opportunity | Rising demand for whole protein and general formulas for kids & adults to help maintain their health is anticipated to aid sales. |
Infant Formula Market:
| Attributes | Infant Formula Market |
|---|---|
| CAGR (2024 to 2034) | 8.7% |
| Growth Factor | Increasing acceptance of infant formula in developing countries other than breast milk is projected to propel the market. |
| Key Trend | Growing cases of premature births worldwide are set to push the need for unique infant formulas, as a mother’s milk alone would not be enough to offer nutrients to the baby. |
| Opportunity | Key companies and government agencies are joining hands to promote the use of organic ingredients in infant formulas. |
Tube Feeding Formula Market:
| Attributes | Tube Feeding Formula Market |
|---|---|
| CAGR (2024 to 2034) | 6.9% |
| Growth Factor | Rising prevalence of metabolic syndrome and high patient care expenditure worldwide are set to support the market. |
| Key Trend | Healthcare providers are recommending the use of tube-feeding formulas in addition to or instead of parenteral formulas to lower the risk of infections. |
| Opportunity | Growing penetration of healthcare units and diagnostic labs across developing countries is projected to create new opportunities. |
The table below showcases the CAGRs of several countries present in the global parenteral formula market. Analysis of these countries would enable potential clients to find the ideal investment area and gain a competitive edge. China and Japan are set to remain at the forefront of the intravenous feeding market by witnessing CAGRs of 5.9% and 5.1%, respectively, from 2024 to 2034.
| Countries | CAGR |
|---|---|
| United States | 3.8% |
| Germany | 4.4% |
| Japan | 5.1% |
| China | 5.9% |
| India | 4.9% |
The United States parenteral formula market is poised to exhibit a CAGR of 3.8% during the assessment period. By 2034, the market size is expected to reach USD 1.9 billion.
Modern healthcare facilities, renowned research institutes, and a highly qualified workforce comprise the United States' first-rate healthcare infrastructure. This infrastructure makes it easier to develop, distribute, and administer parenteral formulas. It also helps in ensuring that patients across the nation receive high-quality medical care.
The United States also has some of the world’s leading manufacturers of parenteral formulas, including Baxter International, B. Braun Melsungen AG, and Fresenius Kabi AG. These companies have strong research & development departments. These enable them to consistently innovate and launch enhanced products, thereby propelling the injectable dietary supplements market.
The parenteral formula market in Germany is anticipated to rise at a steady CAGR of 4.4% during the forecast period from 2024 to 2034. By 2034, the country is set to hold a market share of 18.2% in Europe.
Germany's population is aging swiftly, with a growing number of people over 65. Chronic diseases like diabetes, cancer, and COPD, which frequently require parenteral nutrition for proper feeding, are predicted to increase because of this demographic transition.
Germany has a highly advanced healthcare system that provides every person access to cutting-edge medical care, such as parenteral feeding. One of the main factors fueling demand for parenteral formulations is their accessibility.
Leading companies in the country, like Fresenius Kabi, invest in research & development to launch new parenteral formulas that meet a wide range of patient requirements. By emphasizing innovation, the parenteral nutrition therapy market is set to be competitive and draw in new customers.
Japan’s parenteral formula market is poised to exhibit a CAGR of 5.1% during the assessment period. By 2034, the market is set to reach USD 0.4 billion. Japan is anticipated to hold a share of 13.6% in East Asia by 2034.
Japan has the same age-related change in demographics as other emerging countries. Its high aging population contributes to chronic illnesses like diabetes, cancer, and COPD.
The country values health and wellness with its increasing focus on innovative healthcare practices. This trend translates into a growing demand for customized parenteral formulas tailored to individual patient characteristics, including genetic predispositions, metabolic profiles, and nutritional needs. The rich culture of innovation and technology contributes to the development of efficacious parenteral formulas in Japan.
Check Free Sample Report & Save 40%!
Select your niche segments and personalize your insights for smart savings. Cut costs now!
The table below showcases the top segments and their shares in the global parenteral formula market. Based on sales channels, the online pharmacies segment is projected to generate a share of 12.8% in 2024. By type of nutrient, the electrolytes are anticipated to hold a share of 27.8% in 2024.
| Segment | Parenteral Formula Market Share (2024) |
|---|---|
| Electrolytes (Type of Nutrient) | 27.8% |
| Online Pharmacies (Sales Channels) | 12.8% |
By type of nutrient, the electrolytes segment is expected to register a CAGR of 7.7% from 2024 to 2034. The target segment is set to reach a market value of USD 4.2 billion by 2034.
Electrolytes, including sodium, potassium, chloride, calcium, and magnesium, are the most readily available minerals. They are set to be included in an individual’s diet for preserving fluid balance, controlling muscle & nerve activity, and assisting the body's metabolic functions.
Imbalances can cause serious health problems such as neuromuscular abnormalities, arrhythmias, and dehydration. Electrolyte concentrations can be customized to meet the needs of individual patients with conditions such as fluid restriction, renal dysfunction, or electrolyte abnormalities.
Parenteral formulas with electrolytes have been associated with better patient outcomes, according to studies. They can improve patient well-being, shorten recovery durations, and lower the risk of difficulties. This leads to improved clinical outcomes and reduced healthcare expenses, thereby boosting demand.
The online pharmacies segment is anticipated to thrive at 8.3% CAGR during the projection period. It is set to reach a market valuation of USD 2.3 billion in 2034.
Online pharmacies are anticipated to witness high growth due to customer convenience and accessibility that they offer. Several formulations are available for health conditions, such as neurological diseases, GI disorders, malnutrition, chronic kidney diseases, and cancer care.
The diverse selection allows consumers to explore different brands, formulations, and price points, empowering them to make informed choices that best suit their needs and preferences. This provides consumers with access to a wider range of products than traditional pharmacies.
The parenteral formula market has a diverse and dynamic competitive landscape. Leading companies are focusing on developing new formulations with research & development activities. They are also striving to gain fast track approvals from government agencies to distribute their products worldwide. With rising demand for clean-label products, key companies are joining hands with vendors, suppliers, stakeholders, and research institutes to discover novel ingredients.
For instance
| Attribute | Details |
|---|---|
| Parenteral Formula Market Size (2024) | USD 6.8 billion |
| Parenteral Formula Market Forecast Value (2034) | USD 12.5 billion |
| Global Growth Rate | 5.7% CAGR |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | USD billion for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; and the Middle East & Africa |
| Key Countries Covered | United States, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Poland, China, India, Thailand, Indonesia, Russia, Canada, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, and others. |
| Key Segments Covered | Type of Nutrient, Indications, Sales Channels, and Regions |
| Key Companies Profiled | Baxter International Inc.; B. Braun Melsungen AG; Fresenius Kabi AG; Hospira, Inc. (a subsidiary of Pfizer Inc.); Sichuan Kelun Pharmaceutical Co., Ltd.; Otsuka Pharmaceutical Co., Ltd.; Grifols, S.A.; Aculife Healthcare Private Limited; Vifor Pharma Group; Terumo Corporation; Nutricia (a subsidiary of Danone) |
| Parenteral Formula Market Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Drivers Restraints Opportunity Trends Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The parenteral formula market is set to reach USD 6.8 billion in 2024.
The parenteral formula market is set to witness a 5.7% CAGR through 2034.
Baxter International Inc., B. Braun Melsungen AG, and Fresenius Kabi AG.
North America’s parenteral formula market is set to hold a share of 31.8% in 2034.
Europe is set to hold 27.3% of the parenteral formula market share by 2034
It provides fats, proteins, vitamins, and carbohydrates in liquid form.
Rising demand for personalized nutrition therapy is a key trend.
Intravenous, intradermal, intramuscular, and subcutaneous.
It contains electrolytes, water, lipids, vitamins, proteins, and carbohydrates.
| Market Size (2024E) | USD 50,126 million |
|---|---|
| Market Value (2034F) | USD 1,15,326 million |
| Value-based CAGR (2024 to 2034) | 8.7% |
| Estimated Market Size (2024E) | USD 7,524.6 million |
|---|---|
| Projected Market Value (2034F) | USD 23,874.5 million |
| Value-based CAGR (2024 to 2034) | 11.2% |
| Estimated Market Size (2023E) | USD 586.2 million |
|---|---|
| Projected Market Value (2033F) | USD 1,182.4 million |
| Market CAGR (2023 to 2033) | 7.2% |
| Market Size in 2023 | USD 17,160 million |
|---|---|
| Market Forecast in 2033 | USD 29,648.6 million |
| Market CAGR (2023 to 2033) | 6% |
Explore Food Supplement and Nutrition Insights
View Reports
Parenteral Formula Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
